logo  
Sign in or Register

Already a member?

Sign in

Or sign in with your account on:

Not a member yet?

Register
    

Repros Jumps on Positive Drug Trials

By  +Follow September 17, 2013 8:01AM
Share:
Tickers Mentioned:

Shares in Texas pharma Repros Therapeutics, Inc. (RPRX) gapped up over 30 percent in early morning trading before settling into gains of just over 10 percent on heavy volume as the day wore on. The spike, driven by positive topline results from the most recent study on its drug Androxal® reported after close on Monday, pushed Repros stock to a new 52-week high.

Positive results for Androxal

Androxal is being developed for men of reproductive age with low testosterone due to secondary hypogonadism, which is also associated with obesity and could be among the most common causes of low testosterone. Repros reported that Andorxal met both co-primary endpoints in its second pivotal study, with 81 percent of subjects using the drug experiencing normalized testosterone and no 24-hour average testosterone levels outside of normal ranges. Androxal, which is in a class similar to Sanofi’s (SNY) Clomid®, could receive a strong share of the testosterone replacement therapy (TRT) market because it could also help preserve male fertility while being administered orally, making it significantly more convenient than testosterone replacement injections.  

Possible Sale

Brean Capital initiated coverage of Repros in July of this year, calling it a buy and setting a price target of $32. At the time, analyst Jonathan Aschoff said “Its lead compound Androxal is being evaluated in a Phase 3 program for secondary hypogonadism with results in 4Q13 and 2Q14, which in our view would be key investment catalysts, and we project Androxal launch in mid-2015.” Now, Brean is citing these positive results as a reason for optimism, as well as reports that management may have interest in selling the company. Brean estimated the sell-price potentially reaching $40 a share, in the event that the sale goes down.

In addition to Andorxal, Repros currently has female reproductive drug Proellex® in the pipeline, intended for use in uterine fibroids and endometriosis. “The vaginal formulation of Proellex (Proellex-V) will enter Phase 2b in 2H13 for uterine fibroids with an NDA submission expected in 2016. All compounds are protected by U.S. patents," said Aschoff in July.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions.


Liked What You Read? Join Equities.com as a contributor and get eyeballs on your content FOR FREE!

Results for RPRX
Stockaholics
21 Sep 14 02:38:41
$ELRA closed up 288.89% on over 315 MILLION Volume! Get our new penny stock picks: http://t.co/qloC4OFNEn $ANAC $ACTV $RPRX
Equities.com
19 Sep 14 15:30:31
Repros Therapeutics Inc. (RPRX) Drops 9.81% on September 19 $RPRX http://t.co/t7ahn8rx1M
TheGrimm
19 Sep 14 13:04:47
BMC $RPRX 211,022 share purchased at $9.1: $TKAI 26,660 $18.31 and $DGLY $6.74 all were huge block of shares. Good Night! Cheers
Marie Powers
19 Sep 14 12:57:29
RT @BioWorld: 'Wacho' macho: $RPRX, others hit by FDA panel vote on testosterone replacement therapies. No country for old men http://t.co/…
Mook Trader
19 Sep 14 12:47:43
$RPRX might crack the 8.88 low yesterday. only 15 min left to trade though
Trabuco Roble
19 Sep 14 12:39:13
$RPRX looks ripe for a bounce next week.
BioWorld Today
19 Sep 14 12:38:40
'Wacho' macho: $RPRX, others hit by FDA panel vote on testosterone replacement therapies. No country for old men http://t.co/eQw8NdQwtH
TheGrimm
19 Sep 14 09:12:32
$RPRX bottom buy
Gilly
19 Sep 14 08:45:38
$IMUR $RPRX $NADL $GLDD $ESI $AUY etc etc all down hard
US_proptrader
19 Sep 14 07:18:31
$ACHN $ISIS $JMEI $MPEL $PDLI $PLUG $RPRX $YHOO $ZNGA autocharts @ http://t.co/hj7PGeTQk3
FonsieTrader
19 Sep 14 07:15:35
$RPRX on radar. Might bounce here. Target $12
C Mosseri Marlio
19 Sep 14 07:08:55
RT @pick1998_2: $RPRX huge paper loss today. Still hold my long position, believing that Adroxal to burst endogeneous T is different from e…
Large Void Bot
19 Sep 14 06:35:12
New 52wk Lows: $RPRX
Antonio Costa
19 Sep 14 05:45:39
$RPRX Could rebound from extreme oversold conditions. http://t.co/F2PrwvElwi
♛ ʎןɐʞo uǝʌǝʇs
19 Sep 14 05:20:28
Day trade watches: $PLUG $RAD $RPRX
Dan
19 Sep 14 05:12:05
$RPRX OI for maturity 09/20/2014. 15.00 Highest put. 17.50 Highest call. http://t.co/acz1g8fBT8
Dan
19 Sep 14 05:02:41
$RPRX Max Pain is 15.00 for maturity 09/20/2014. Last close = 10.09. http://t.co/Wx07SY2Boc
luckypete
19 Sep 14 04:34:56
RT @arkur72: Day Trading Watch list for 19.09.2014parrt1 $KKD $EPIQ $FHN $PIR $AVNR $INFN $TGTX $FBR $RPRX $MOBI $VIMC $PDLI $PWE $HPJ $NYN…
Trade Alerts
19 Sep 14 04:34:07
Day Trading Watch list for 19.09.2014parrt1 $KKD $EPIQ $FHN $PIR $AVNR $INFN $TGTX $FBR $RPRX $MOBI $VIMC $PDLI $PWE $HPJ $NYNY $RAD
Stock Rocket
18 Sep 14 23:03:41
$NETE Gained 551.93% In The Past 6 Weeks! Major News: http://t.co/PU7GW934W5 $ANAC $ACTV $RPRX
Large Void
18 Sep 14 21:34:08
Watchlist for 2014-09-19 -- $BABA $RPRX $WPRT $VHC $PDLI $PAC $WLT
ollielindsay
18 Sep 14 21:22:00
Down on unusual Vol Sep 18: $RPRX $PIR $EPR $NEWM $CLR $SNE $YRCW $BTU $YHOO $SHLD $DNKN $AVNR $WLL $WPRT
$$$ Money $$$
18 Sep 14 20:06:46
$ARQL $ANTH $CYTX $SGYP $GTXI $RPRX bios hitting 52wks low today. Yikes! $SGYP seem like strong candidate for bounce run up.
DayTrading Power
18 Sep 14 19:15:38
Daytraded #stocks : $TKMR $VVUS $CZR $JD $SFUN $RPRX $PWE $AMBA $STX $CY $XXII $SWKS $YHOO $CIDM $TWTR went 16/20 for +$1200 including O/N
MAISA
18 Sep 14 18:11:16
#52WeeksLow today = $CYTX $0.94 = $ECTE $0.97 = $MELA $1.89 = $RPRX $10.09
MAISA
18 Sep 14 16:47:31
$RPRX $LCPN #FDA was concerned doctors were prescribing such drugs too openly to middle-aged men
MAISA
18 Sep 14 16:46:45
$RPRX Slumps To New 18-Month Low As FDA Panel Roadblocks Low-Testosterone Drugs
Dr. Tro Kalayjian
18 Sep 14 16:24:38
RT @FDAadcomm: AdCom VOTE: Should #FDA revise the indication for testosterone? 20-Yes 1-No $ENDP $AUXL $CLRS $ABBV $ACT $AUXL $ENDP $RPRX $…
Equities.com
18 Sep 14 16:02:50
Repros Therapeutics Inc. (RPRX) Drops 21.66% on September 18 $RPRX http://t.co/32VhG776n7
US Banking News
18 Sep 14 15:56:54
Repros Therapeutics Hits New 52-Week Low at $8.88 $RPRX http://t.co/WU1qAs7jI1
Dan
18 Sep 14 15:36:36
$RPRX high open interest range is 15.00 to 17.50 for option expiration 09/20/2014. http://t.co/acz1g8fBT8
Dan
18 Sep 14 15:24:31
$RPRX Max Pain = 15.00. Maturity = 09/20/2014. Previous close = 10.09. http://t.co/Wx07SY2Boc
4-traders.com
18 Sep 14 15:10:05
Repros Therapeutics : Nasdaq stocks posting largest percentage decreases http://t.co/PM7RPEuOw2 $RPRX $LPCN
Bidness Etc
18 Sep 14 14:50:39
Repros Therapeutics Stock Sinks Following Advisory Committee Vote http://t.co/09Gz5FWsyp $RPRX $ABBV
Antonio Costa
18 Sep 14 14:19:29
RT @dougheuringaria: $rprx comments ladenberg http://t.co/Ax5aocncre
Antonio Costa
18 Sep 14 14:19:21
RT @dougheuringaria: Brean Capital Maintains Bullish Stance On Repros, $41 PT $rprx http://t.co/FSHFTRfcM3
S Manian
18 Sep 14 14:19:12
RT @dougheuringaria: Brean Capital Maintains Bullish Stance On Repros, $41 PT $rprx http://t.co/FSHFTRfcM3
S Manian
18 Sep 14 14:18:49
RT @dougheuringaria: $rprx comments ladenberg http://t.co/Ax5aocncre
Erythrosine
18 Sep 14 14:18:03
RT @dougheuringaria: $rprx ladenberg comments 35pt http://t.co/KRwq1eEpxm
S Manian
18 Sep 14 14:18:03
RT @dougheuringaria: $rprx ladenberg comments 35pt http://t.co/KRwq1eEpxm
dougheuring
18 Sep 14 14:05:57
$rprx ladenberg comments 35pt http://t.co/KRwq1eEpxm
Daily Contracts
18 Sep 14 13:33:01
Real-Time feed of company contracts, original agreements and executive updates from Repros Therapeutics Inc. $RPRX http://t.co/pdlwyhJUXW
Daily Contracts
18 Sep 14 13:08:02
Real-Time feed of company contracts, original agreements and executive updates from Repros Therapeutics Inc. $RPRX http://t.co/pdlwyhJUXW
TK
18 Sep 14 13:02:41
RT @JohnCFierce: If Clarus is toast - and it looks that way. Then Repros is in serious trouble. $RPRX
Livevol Community
18 Sep 14 13:00:07
Gainers: $EMKR+26.11% $PRQR+11.62% $VIMC+10.57% Losers: $VHC-25.98% $RPRX-23.52% $RAD-19.18% Stock Movers Report: http://t.co/urlxNiW1Ky
Antonio Costa
18 Sep 14 12:59:06
$RPRX making a nice bounce now
TheGrimm
18 Sep 14 12:56:34
Great run eod $RPRX may gap tomorrow..$GNC will be interesting too but will not hold overnight.
Nick zheng
18 Sep 14 12:48:26
$RPRX huge paper loss today. Still hold my long position, believing that Adroxal to burst endogeneous T is different from exogeneous T patch
C. Michael Gibson MD
18 Sep 14 12:48:10
RT @JohnCFierce: If Clarus is toast - and it looks that way. Then Repros is in serious trouble. $RPRX
César Segovia
18 Sep 14 12:42:44
US $1700 de beneficios hoy, todas mis operaciones alertadas en tiempo real $NYNY $RPRX. ¡Espero que hayas tenido un excelente día!
				
				
By  +Follow September 17, 2013 8:01AM
Share:

Comments

 

blog comments powered by Disqus

About us

Equities.com is the most advanced interactive online social ecosystem for the financial industry, serving as a resource center and next-generation communication platform that connects self-directed investors with public issuers, market experts, and professional service providers and vendors. Registered members can leverage our exclusive proprietary research tools such as the Small-Cap Stars, which outperformed 90% of all small-cap mutual funds, and robust do-it-yourself E.V.A. research reports. The Equities.com Issuer Dashboard is the ideal tool to communicate and manage investor awareness campaigns to the investment community, as well as to access valuable resources to help your company grow.

Market Data powered by QuoteMedia.
Copyright © QuoteMedia. Data delayed 15 minutes unless otherwise indicated. Terms of Use.